BOT - Anything but charting, page-10557

The statistical data that there is 10M active people with Hyperhidrosis condition is one data set.

But the fact that 3.7M have actively got off their backsides and spent the time, effort and costs to have their condition formerly diagnosed is encouraging in reference to the % of that 3.7M market Sofdra can capture.

I would also inference that the degree to which they suffer from Hyperhidrosis is significant enough (for them to seek diagnosis and treatment) that a decent percentage of this cohort would need a form of treatment to be able to live a normal content life and would be willing to pay money for this.

Coverage under insurance plans to offset a chunk of the related cost would be massive for BOT and revenue potential and how fast the take up and trajectory is.